BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR-Reference-Cited by-同舟云学术

BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR

Published:2012-08-20 Issue:8 Volume:17 Page:9971-9989
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Sliwoski Gregory,Lowe Edward W.,Butkiewicz Mariusz,Meiler Jens

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/17/8/9971/pdf

Reference40 articles.

1. Basic Principles of the CIP-System and Proposals for a Revision

2. Influence of chirality of amino acids on the growth of perceived taste intensity with concentration

3. Recent advances in chirally pure proton pump inhibitors;Pai;J. Indian Med. Assoc.,2007

4. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans;Mehvar;J. Pharm. Pharm. Sci.,2001

5. The future lies in chiral purity: A perspective;Gurjar;J. Indian Med. Assoc.,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpretable Chirality-Aware Graph Neural Network for Quantitative Structure Activity Relationship Modeling in Drug Discovery;2022-08-26

2. General Purpose Structure-Based Drug Discovery Neural Network Score Functions with Human-Interpretable Pharmacophore Maps;Journal of Chemical Information and Modeling;2021-01-26

3. Software tools for toxicology and risk assessment;Information Resources in Toxicology;2020

4. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent;Recent Patents on Anti-Cancer Drug Discovery;2017-06-05

5. Improving quantitative structure–activity relationship models using Artificial Neural Networks trained with dropout;Journal of Computer-Aided Molecular Design;2016-02